Re-induction of hormonal sensitivity in hormone-refractory prostate cancer--fact or fiction?
Berry
William R
WR
US Oncology, Houston, TX, USA. william.berry@usoncology.com
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002699:Chlorambucil / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D002699:Chlorambucil; D008130:Lomustine